Citius Pharmaceuticals Inc.

CTXR | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.58

-$0.02 (-3.33%)

At close: Sep 21, 2026, 4:00 PM ET

$0.58

$0 (-0.60%)

Pre-market: Sep 22, 2026, 8:55 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Net Income	-39.74M	-39.43M	-32.54M	-33.64M	-23.05M	-17.55M
Depreciation & Amortization	214.25K	209.61K	194.32K	179.68K	164.87K	152.36K
Stock-Based Compensation	10.84M	11.84M	6.62M	3.91M	1.45M	803.26K
Other Working Capital	4.94M	-1.55M	-5.77M	351.27K	-2.14M	-9.66K
Other Non-Cash Items	26.6K	284.18K	102K	378.2K	68K	528.77K
Deferred Income Tax	1.06M	576K	576K	576K	-166.56K	n/a
Change in Working Capital	1.05M	-1.69M	-4.01M	239.56K	-2.72M	-866.97K
Operating Cash Flow	-26.55M	-28.2M	-29.06M	-28.36M	-24.25M	-16.93M
Capital Expenditures	n/a	n/a	n/a	n/a	-40.01M	-1.83K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5M	n/a	n/a	n/a	n/a
Investing Cash Flow	-5.75M	-5M	n/a	n/a	-40.01M	-1.83K
Debt Repayment	1M	n/a	n/a	n/a	-172.97K	164.58K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-3.83M	31.27K	n/a	31.21M	7.16M
Financial Cash Flow	33.3M	9.97M	13.83M	n/a	120.47M	22.9M
Net Cash Flow	1M	-23.23M	-15.23M	-28.36M	56.21M	5.97M
Free Cash Flow	-26.55M	-28.2M	-29.06M	-28.36M	-64.26M	-16.93M
Adj. Free Cash Flow	-37.39M	-40.04M	-35.68M	-32.27M	-65.71M	-17.74M
Maintenance CapEx	n/a	n/a	n/a	n/a	-164.87K	-1.83K
Growth CapEx	n/a	n/a	n/a	n/a	-39.84M	n/a
Owner Earnings	-26.55M	-28.2M	-29.06M	-28.36M	-24.42M	-16.93M